Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities

    NEXT STORY
    Myriad Will Seek FDA Approval of BRACAnalysis CDx® As a Companion Diagnostic for Lynparza® (olaparib) In Men with Metastatic Castrate-Resistant Prostate Cancer
    PREV STORY
    Cyclacel Pharmaceuticals to Release Second Quarter 2019 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    National Cancer Institute selects Apexian Pharmaceuticals to participate in the Small Business Innovation Research (SBIR) Initiative program

    Indianapolis, Indiana, USA, Sept. 27, 2017 (GLOBE NEWSWIRE) --                                                                                                                                           FOR IMMEDIATE RELEASE National ...

    author_avatar
    NASDAQ Market News

    Castle Connolly Medical Ltd. Continues to Expand Its Database of Top Doctors Across the U.S.

    New York, NY, May 15, 2018 (GLOBE NEWSWIRE) -- Castle Connolly Medical Ltd. (www.castleconnolly.com) ...

    author_avatar
    NASDAQ Market News

    Eurobio Scientific and Vivo Medical Group enter into exclusive negotiations for the acquisition of two companies in the United Kingdom

    author_avatar
    NASDAQ Market News